Core Viewpoint - RXO Inc. is facing significant financial challenges, including an operating loss and margin pressures, while maintaining a Neutral rating from UBS with a revised price target indicating potential stability in its stock value [1][5]. Financial Performance - In Q4 2025, RXO reported an operating loss of $42 million and nearly negative EBITDA, highlighting the difficulties in covering operating expenses [2][5]. - For Q1 2026, RXO anticipates EBITDA to range between $5 million and $12 million, which is insufficient to cover interest expenses, raising concerns about debt management [3][5]. Market Activity - RXO's stock has shown volatility, with a recent price increase of $0.32, or approximately 1.93%, and trading between a low of $15.03 and a high of $17.42 during the trading day [4]. - Over the past year, the stock peaked at $22.17 and reached a low of $10.42, with a market capitalization of approximately $2.77 billion and a trading volume of 6.24 million shares [4].